InvestSMART

EMvision Medical Devices Limited (ASX:EMV)

ALERT: Price-sensitive ASX Announcement for EMV
Current share price for EMV : $1.530 -0.24 (-13.56%)+
Announcement
Release
31 Oct 2025 10:42AM
Price at Release
$1.770
Full Release
download
Summary
EMVision Medical Devices Limited, traded on the ASX as EMV, announced the successful completion of an oversubscribed Share Purchase Plan (SPP) raising $2.0 million. This was part of a larger capital raising initiative by the company, which included a recently completed $12.0 million placement, totaling $14.0 million in funds raised. These funds are intended to support significant company milestones such as pivotal trial readout, FDA submission, and commercialization of their emuTM device, along with advancing the First Responder program through various stages including clinical trials and regulatory preparation. The SPP saw high demand, requiring scale-back of applications, with preference given to earlier participants and equitable distribution among shareholders. EMVision, based in Australia, is focused on developing portable, non-invasive neurodiagnostic devices aimed at improving diagnosis and treatment of stroke and other medical emergencies at the point-of-care.
Key Points
  • EMVision raised $2.0 million from an oversubscribed Share Purchase Plan.
  • Total funds raised through recent efforts amounted to $14.0 million.
  • Funds will be used for pivotal trials, FDA submission, and commercialization of the emuTM device.
  • The Share Purchase Plan required scale-back due to high demand.
  • EMVision focuses on portable neurodiagnostic devices for emergency medical use.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.